Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the investigational drug catumaxomab
delivered in the planned treatment schedule is a safe and effective treatment for women with
advanced ovarian cancer who experience a complete response to chemotherapy.